Search tips
Search criteria 


Logo of molmedLink to Publisher's site
Mol Med. 1996 May; 2(3): 373–383.
PMCID: PMC2230144

Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin.


BACKGROUND: Lipopolysaccharides (LPS), widely used to study the mechanisms of gram-negative sepsis, increase airway resistance by constriction of terminal bronchioles. The role of the cyclooxygenase (COX) isoenzymes and their prostanoid metabolites in this process was studied. MATERIALS AND METHODS: Pulmonary resistance, the release of thromboxane (TX) and the expression of COX-2 mRNA were measured in isolated blood-free perfused rat lungs exposed to LPS. RESULTS: LPS induced the release of TX and caused increased airway resistance after about 30 min. Both TX formation and LPS-induced bronchoconstriction were prevented by treatment with the unspecific COX inhibitor acetyl salicylic acid, the specific COX-2 inhibitor CGP-28238, dexamethasone, actinomycin D, or cycloheximide. LPS-induced bronchoconstriction was also inhibited by the TX receptor antagonist BM-13177. The TX-mimetic compound, U-46619, increased airway resistance predominantly by constricting terminal bronchioles. COX-2-specific mRNA in lung tissue was elevated after LPS exposure, and this increase was attenuated by addition of dexamethasone or of actinomycin D. In contrast to LPS, platelet-activating factor (PAF) induced immediate TX release and bronchoconstriction that was prevented by acetyl salicylic acid, but not by CGP-28238. CONCLUSIONS: LPS elicits the following biochemical and functional changes in rat lungs: (i) induction of COX-2; (ii) formation of prostaglandins and TX; (iii) activation of the TX receptor on airway smooth muscle cells; (iv) constriction of terminal bronchioles; and (v) increased airway resistance. In contrast to LPS, the PAF-induced TX release is likely to depend on COX-1.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Sep;138(3):720–723. [PubMed]
  • Uhlig S, Brasch F, Wollin L, Fehrenbach H, Richter J, Wendel A. Functional and fine structural changes in isolated rat lungs challenged with endotoxin ex vivo and in vitro. Am J Pathol. 1995 May;146(5):1235–1247. [PubMed]
  • Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis. 1986 May;133(5):913–927. [PubMed]
  • Forsgren P, Modig J. Lung mechanics with relation to pulmonary haemodynamics, gas exchange and extravascular lung water in mechanically ventilated endotoxaemic pigs. Acta Chir Scand. 1986 Oct;152:561–568. [PubMed]
  • Hardie EM, Olson NC. Prostaglandin and thromboxane levels during endotoxin-induced respiratory failure in pigs. Prostaglandins Leukot Med. 1987 Aug;28(3):255–265. [PubMed]
  • O'Sullivan MG, Huggins EM, Jr, Meade EA, DeWitt DL, McCall CE. Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem Biophys Res Commun. 1992 Sep 16;187(2):1123–1127. [PubMed]
  • Hempel SL, Monick MM, Hunninghake GW. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest. 1994 Jan;93(1):391–396. [PMC free article] [PubMed]
  • Mitchell JA, Belvisi MG, Akarasereenont P, Robbins RA, Kwon OJ, Croxtall J, Barnes PJ, Vane JR. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol. 1994 Nov;113(3):1008–1014. [PMC free article] [PubMed]
  • Uhlig S, Wollin L. An improved setup for the isolated perfused rat lung. J Pharmacol Toxicol Methods. 1994 Apr;31(2):85–94. [PubMed]
  • Bahrami S, Redl H, Leichtfried G, Yu Y, Schlag G. Similar cytokine but different coagulation responses to lipopolysaccharide injection in D-galactosamine-sensitized versus nonsensitized rats. Infect Immun. 1994 Jan;62(1):99–105. [PMC free article] [PubMed]
  • Chang SW. Endotoxin-induced lung vascular injury: role of platelet activating factor, tumor necrosis factor and neutrophils. Clin Res. 1992 Oct;40(3):528–536. [PubMed]
  • Sprague RS, Stephenson AH, Dahms TE, Lonigro AJ. Proposed role for leukotrienes in the pathophysiology of multiple systems organ failure. Crit Care Clin. 1989 Apr;5(2):315–329. [PubMed]
  • Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Frenette R, Gauthier JY, Leger S, Masson P, et al. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol. 1989 Jan;67(1):17–28. [PubMed]
  • Uhlig S, Wollin L, Wendel A. Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. J Appl Physiol (1985) 1994 Jul;77(1):262–269. [PubMed]
  • Ball HA, Parratt JR, Zeitlin IJ. Effect of dazoxiben, a specific inhibitor of thromboxane synthetase, on acute pulmonary responses to E. coli endotoxin in anaesthetized cats. Br J Clin Pharmacol. 1983;15 (Suppl 1):127S–131S. [PMC free article] [PubMed]
  • Klein T, Nüsing RM, Pfeilschifter J, Ullrich V. Selective inhibition of cyclooxygenase 2. Biochem Pharmacol. 1994 Oct 18;48(8):1605–1610. [PubMed]
  • Masferrer JL, Seibert K, Zweifel B, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3917–3921. [PubMed]
  • Hong SL, Levine L. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A. 1976 May;73(5):1730–1734. [PubMed]
  • Chang SW, Westcott JY, Pickett WC, Murphy RC, Voelkel NF. Endotoxin-induced lung injury in rats: role of eicosanoids. J Appl Physiol (1985) 1989 May;66(5):2407–2418. [PubMed]
  • Barnard JW, Ward RA, Adkins WK, Taylor AE. Characterization of thromboxane and prostacyclin effects on pulmonary vascular resistance. J Appl Physiol (1985) 1992 May;72(5):1845–1853. [PubMed]
  • Carpenter LJ, Roth RA. Involvement of thromboxane in injury to isolated rat lungs perfused with phorbol myristate acetate in the presence and absence of neutrophils. Toxicol Appl Pharmacol. 1987 Oct;91(1):33–45. [PubMed]
  • Nüsing R, Ullrich V. Immunoquantitation of thromboxane synthase in human tissues. Eicosanoids. 1990;3(3):175–180. [PubMed]
  • Oettinger W, Mayo K, Stager MA, Fischer N, Engst U, Hansen ST., Jr Thromboxan-A2 und Granulozyten-Elastase nach schwerem Trauma--Beziehungen zu Verlaufskomplikationen und Uberlebensraten. Wien Klin Wochenschr. 1989 Dec 8;101(23):805–813. [PubMed]
  • Freudenberg N, Freudenberg MA, Guzman J, Mittermayer C, Bandara K, Galanos C. Identification of endotoxin-positive cells in the rat lung during shock. Virchows Arch A Pathol Anat Histopathol. 1984;404(2):197–211. [PubMed]
  • Feuerstein N, Ramwell PW. In vivo and in vitro effects of endotoxin on prostaglandin release from rat lung. Br J Pharmacol. 1981 Jun;73(2):511–516. [PMC free article] [PubMed]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ